Connect with us

Health

IITK Researchers Unveils Key Receptor Structure for Cancer and Respiratory Treatments

The team successfully visualized the atomic structure of CXCR2, a crucial human receptor involved in the progression of cancer and respiratory diseases

Published

on

GPCR Lab. Image credit: By special arrangement

Researchers from the Department of Biological Sciences and Bioengineering at the Indian Institute of Technology (IIT) Kanpur have made a path breaking discovery that could pave the way for new treatments for cancer and respiratory diseases. The team successfully visualized the atomic structure of CXCR2, a crucial human receptor involved in the progression of these diseases. Their findings, published in the prestigious journal Molecular Cell, offer a new perspective on targeting this receptor for therapeutic intervention.

CXCR2 is a key receptor in the immune system, involved in directing immune cells to infection and injury sites through interaction with chemokines—small signaling proteins. CXCR2’s role in inflammatory disorders and cancers such as chronic obstructive pulmonary disease (COPD), asthma, atherosclerosis, and pancreatic cancer makes it a promising target for new drugs.

Using advanced cryogenic-electron microscopy (cryo-EM), the IIT Kanpur researchers captured unprecedented details of the receptor’s “lock-and-key” mechanism, shedding light on how CXCR2 interacts with multiple chemokines. This discovery addresses a fundamental question in biomedical science about how a single receptor can bind to various chemokines and trigger biological responses. The visualization also opens up opportunities for designing novel therapeutics.

“Our findings provide a molecular blueprint for designing next-generation therapeutics that can precisely target CXCR2 and potentially reduce its role in cancer and respiratory diseases. By visualizing this receptor in its active state, we now have the opportunity to develop highly specific inhibitors that can disrupt its function, potentially leading to significant advancements in treatment strategies,” said Professor Arun Kumar Shukla, the lead investigator of the study at IIT Kanpur.

The research team at IIT Kanpur includes Shirsha Saha, Saloni Sharma, Manisankar Ganguly, Nashrah Zaidi, Divyanshu Tiwari, Nabarun Roy, Nilanjana Banerjee, and Ramanuj Banerjee. Their work also involved collaboration with experts from the University of Tokyo, Japan—Fumiya Sano, Hiroaki Akasaka, Takaaki Kobayashi, Yuzuru Itoh, Wataru Shihoya, and Osamu Nureki—along with Andy Chevigne from the Luxembourg Institute of Health.

This study was funded by the DBT Wellcome Trust India Alliance, Science and Engineering Research Board (SERB), Indian Council of Medical Research (ICMR), and LADY TATA Memorial Trust.

Building on this discovery, the IIT Kanpur team is now developing small molecules and antibodies aimed at targeting CXCR2. These therapeutics will undergo laboratory testing, followed by animal studies, bringing the team closer to offering innovative treatments for cancer and respiratory diseases. This achievement further underscores IIT Kanpur’s commitment to pioneering research that has the potential to revolutionize global healthcare and biomedical innovation.

Health

Researchers Unveil 50-Cent DNA Sensors That Could Revolutionize Disease Diagnosis

The innovation lies in a low-cost electrochemical sensor stabilized with a polymer coating, which allows the device to be stored for months at high temperatures and used far from traditional lab settings

Published

on

Credit: Courtesy of the researchers; edited by MIT News

In a breakthrough that could make life-saving diagnostics accessible to millions, MIT researchers have developed a disposable, DNA-coated sensor capable of detecting diseases like cancer, HIV, and influenza — all for just 50 cents. The innovation lies in a low-cost electrochemical sensor stabilized with a polymer coating, which allows the device to be stored for months at high temperatures and used far from traditional lab settings.

At the heart of this sensor is a CRISPR-based enzyme system. When the sensor detects a target disease gene, the enzyme — acting like a molecular lawnmower — begins to shred DNA on the electrode, disrupting the electric signal and indicating a positive result.

“Our focus is on diagnostics that many people have limited access to, and our goal is to create a point-of-use sensor,” said Ariel Furst, MIT chemical engineering professor and senior author of the study, in a media statement. “People wouldn’t even need to be in a clinic to use it. You could do it at home.”

Previously, such sensors faced a major hurdle: the DNA coating degraded rapidly, requiring immediate use and refrigerated storage. Furst’s team overcame this by using polyvinyl alcohol (PVA) — a cheap and widely available polymer — to form a protective film over the DNA, significantly extending shelf life.

The sensors were tested to successfully detect PCA3, a prostate cancer biomarker found in urine, even after two months of storage at 150°F. The technology builds on Furst’s earlier work that enabled detection of HIV and HPV genetic material using similar CRISPR-based methods.

“This is the same core technology used in glucose meters, but adapted with programmable DNA,” said lead author Xingcheng Zhou, an MIT graduate student. “It’s inexpensive, portable, and extremely versatile.”

The team now aims to expand testing for other infectious and emerging diseases. They’ve been accepted into MIT’s delta v venture accelerator, signaling commercial interest and real-world application potential. The ability to ship sensors without refrigeration could be transformative for low-resource and remote settings.

“Our limitation before was that we had to make the sensors on site,” added Furst. “Now that we can protect them, we can ship them. That allows us to access a lot more rugged or non-ideal environments for testing.”

With further development, these pocket-sized DNA sensors could redefine early disease detection — from rural clinics to living rooms.

Continue Reading

Health

Teak Leaf Extract Emerges as Eco-Friendly Shield Against Harmful Laser Rays

Raman Research Institute scientists unlock sustainable alternative for laser safety in line with green tech goals

Published

on

In a significant step toward sustainable photonic technologies, scientists from the Raman Research Institute (RRI), an autonomous institute under the Department of Science and Technology (DST), Government of India, have discovered that teak leaf extract can serve as an effective, natural shield against harmful laser radiation. This breakthrough offers new potential for protecting both sensitive optical sensors and human eyes from high-intensity lasers used in medical, industrial, and defense applications.

The team has found that the otherwise discarded leaves of the teak tree (Tectona grandis L.f) are rich in anthocyanins, natural pigments responsible for their reddish-brown colour. When exposed to light, these pigments exhibit nonlinear optical (NLO) properties, allowing them to absorb intense laser beams—a key feature required for laser safety gear.

The discovery, recently published in the Journal of Photochemistry and Photobiology A: Chemistry, proposes a non-toxic, biodegradable, and cost-effective alternative to conventional synthetic materials like graphene and metal nanoparticles, which are often expensive and environmentally hazardous.

“Teak leaves are a rich source of natural pigments such as anthocyanin… We explored the potential of teak leaf extract as an eco-friendly alternative to synthetic dyes in the field of nonlinear optics,” said Beryl C, DST Women Scientist at RRI, in a media statement issued by the government.

To extract this natural dye, researchers dried and powdered teak leaves, soaked them in solvents, and processed the mixture using ultrasonication and centrifugation. The resulting reddish-brown liquid was then tested with green laser beams under continuous and pulsed conditions.

Using advanced techniques like Z-scan and Spatial Self-Phase Modulation (SSPM), the dye demonstrated reverse saturable absorption (RSA)—a rare and desirable trait where the material absorbs more light as the intensity increases, effectively acting as a self-regulating shield against laser exposure.

This development is particularly crucial as laser technologies become increasingly prevalent in everyday environments—from surgical devices and industrial cutters to military-grade systems. By offering a natural and renewable solution to a global safety challenge, the RRI team has opened the door to a future of eco-conscious optical safety equipment, such as laser-resistant eyewear, coatings, and sensor shields.

Researchers also indicated that further studies will focus on enhancing the stability and commercial usability of the dye for long-term deployment.

This innovation aligns with the principles of Industry 5.0, emphasizing human-centered and environmentally responsible technology, and showcases how indigenous, sustainable resources can play a pivotal role in global tech solutions.

Continue Reading

Health

PUPS – the AI tool that can predict where exactly proteins are in human cells

Dubbed, the Prediction of Unseen Proteins’ Subcellular Localization (or PUPS), the AI tool can account for the effects of protein mutations and cellular stress—key factors in disease progression.

Published

on

Credits:Image: Courtesy of the researchers; MIT News

Researchers from MIT, Harvard University, and the Broad Institute have unveiled a groundbreaking artificial intelligence tool that can accurately predict where proteins are located within any human cell, even if both the protein and cell line have never been studied before. The method – Prediction of Unseen Proteins’ Subcellular Localization (or PUPS) – marks a major advancement in biological research and could significantly streamline disease diagnosis and drug discovery.

Protein localization—the precise location of a protein within a cell—is key to understanding its function. Misplaced proteins are known to contribute to diseases like Alzheimer’s, cystic fibrosis, and cancer. However, identifying protein locations manually is expensive and slow, particularly given the vast number of proteins in a single cell.

The new technique leverages a protein language model and a sophisticated computer vision system. It produces a detailed image that highlights where the protein is likely to be located at the single-cell level, offering far more precise insights than many existing models, which average results across all cells of a given type.

“You could do these protein-localization experiments on a computer without having to touch any lab bench, hopefully saving yourself months of effort. While you would still need to verify the prediction, this technique could act like an initial screening of what to test for experimentally,” said Yitong Tseo, a graduate student in MIT’s Computational and Systems Biology program and co-lead author of the study, in a media statement.

Tseo’s co-lead author, Xinyi Zhang, emphasized the model’s ability to generalize: “Most other methods usually require you to have a stain of the protein first, so you’ve already seen it in your training data. Our approach is unique in that it can generalize across proteins and cell lines at the same time,” she said in a media statement.

PUPS was validated through laboratory experiments and shown to outperform baseline AI methods in predicting protein locations with greater accuracy. The tool is also capable of accounting for the effects of protein mutations and cellular stress—key factors in disease progression.

Published in Nature Methods, the research was led by senior authors Fei Chen of Harvard and the Broad Institute, and Caroline Uhler, the Andrew and Erna Viterbi Professor at MIT. Future goals include enabling PUPS to analyze protein interactions and make predictions in live human tissue rather than cultured cells.

Continue Reading

Trending